This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (56)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Janak Kumari, MD, MRCP

Arch Dermatol. 1984;120(5):631-635.

Abstract
• Seventy-five patients with vitiligo were treated with intermittent topical applications of clobetasol propionate for varying times within a three-year period. The best results occurred in the facial lesions of Asian or black patients. Repigmentation of 90% to 100% was achieved in more than 80% of patients with vitiligo of the face and more than 40% of patients with vitiligo on other parts of the body. Progressive repigmentation continued even after the treatment stopped. Intermittent therapy helped to avoid the problems of adverse local effects from the use of potent adrenal steroids.

(Arch Dermatol 1984;120:631-635)

Author Affiliations
From the Department of Dermatology, The General Hospital, Steelhouse Lane, Birmingham, England.

Footnotes
Accepted for publication July 19, 1983.

Reprint requests to Department of Dermatology, The General Hospital, Steelhouse Lane, Birmingham B4 6NH, England.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Left-Right Comparison Study of the Combination of Fluticasone Propionate and UV-A vs Either Fluticasone Propionate or UV-A Alone for the Long-term Treatment of Vitiligo
Westerhof et al.
Arch Dermatol 1999;135:1061-1066.
ABSTRACT | FULL TEXT  

Treatment of Localized Vitiligo by Autologous Minigrafting
Falabella
Arch Dermatol 1988;124:1649-1655.
ABSTRACT  

Vitiligo
Scholtz
Arch Dermatol 1985;121:21-22.
ABSTRACT